Related Experiment Video
Updated: Jul 17, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Cestode vaccines: origins, current status and future prospects.
1Veterinary Clinical Centre, University of Melbourne, 250 Princes Highway, Werribee, Victoria 3030, Australia. marshall@unimelb.edu.au
Parasitology
|February 6, 2007
Summary
Recombinant vaccines effectively prevent parasitic infections in livestock. Vaccines targeting zoonotic parasites like Echinococcus granulosus and Taenia solium are crucial for public health, requiring public support for development and production.
Area of Science:
- Veterinary Parasitology
- Vaccinology
- Public Health
Background:
- Recombinant vaccines demonstrate high efficacy against Taenia ovis, Taenia saginata, Taenia solium, and Echinococcus granulosus in livestock.
- Taenia ovis and Taenia saginata infections have significant economic impacts on livestock farming.
- Echinococcus granulosus and Taenia solium are zoonotic parasites responsible for cystic hydatid disease and neurocysticercosis in humans, respectively.
Purpose of the Study:
- To evaluate the development and potential of recombinant vaccines against significant livestock and zoonotic parasites.
- To highlight the challenges and necessity of public sector support for orphan vaccines targeting zoonotic diseases prevalent in developing regions.
- To emphasize the importance of commercial-scale production and partnerships for the successful implementation of these vaccines.
Main Methods:
- Development of recombinant vaccines targeting specific parasitic antigens.
- Assessment of vaccine efficacy in relevant livestock models.
- Analysis of economic factors influencing vaccine commercialization.
- Evaluation of public health impact and disease control strategies.
Main Results:
- High efficacy of recombinant vaccines against target parasites in livestock.
- Identification of Echinococcus granulosus and Taenia solium vaccines as critical for controlling human diseases (orphan vaccines).
- Significant challenges in commercialization due to limited market interest, necessitating public sector involvement.
Conclusions:
- Recombinant vaccines offer a promising approach to control both livestock and zoonotic parasitic infections.
- Public sector support is essential for the development, scale-up, and commercialization of orphan vaccines against neglected zoonotic diseases.
- Strategic partnerships are crucial to realize the full potential of these vaccines in disease control programs.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:51Vaccinations
Overview
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...